Analysis of the Molecular Mechanisms by Flavonoids with Potential Use for Osteoporosis Prevention or Therapy
Valeria Rodríguez1, María Rivoira1, Gabriela Picotto1
1Laboratorio "Dr. Fernando Cañas", Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Background:
Osteoporosis is the most common skeletal disorder worldwide. Flavonoids have the potential to alleviate bone alterations in osteoporotic patients with the advantage of being safer and less expensive than conventional therapies.
Objective:
The main objective is to analyze the molecular mechanisms triggered in bone by different subclasses of flavonoids. In addition, this review provides an up-to-date overview of the cellular and molecular aspects of osteoporotic bones versus healthy bones, and a brief description of some epidemiological studies indicating that flavonoids could be useful for osteoporosis treatment.
Methods:
The PubMed database was searched in 2001- 2021 using the keywords osteoporosis, flavonoids, and their subclasses such as flavones, flavonols, flavanols, isoflavones, flavanones and anthocyanins, focusing the data on the molecular mechanisms triggered in bone.
Results:
Although flavonoids comprise many compounds that differ in structure, their effects on bone loss in postmenopausal women or in ovariectomized-induced osteoporotic animals are quite similar. Most of them increase bone mineral density and bone strength, which occur through an enhancement of osteoblastogenesis and osteoclast apoptosis, a decrease in osteoclastogenesis, as well as an increase in neovascularization on the site of the osteoporotic fracture.
Conclusion:
Several molecules of signaling pathways are involved in the effect of flavonoids on osteoporotic bone. Whether all flavonoids have a common mechanism or they act as ligands of estrogen receptors remains to be established. More clinical trials are necessary to know better their safety, efficacy, delivery and bioavailability in humans, as well as comparative studies with conventional therapies.
Insights
Flavonoids show promise for treating osteoporosis by improving bone density and strength. These natural compounds enhance bone formation and reduce bone loss, offering a safer alternative to traditional therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Osteoporosis is a prevalent skeletal disorder globally.
- Flavonoids offer a safer, cost-effective therapeutic potential for bone alterations in osteoporosis.
- They present an alternative to conventional osteoporosis treatments.
Purpose of the Study:
- To investigate the molecular mechanisms of flavonoids in bone.
- To review cellular and molecular differences between healthy and osteoporotic bone.
- To summarize epidemiological data on flavonoid efficacy for osteoporosis.
Main Methods:
- Searched PubMed (2001-2021) for studies on osteoporosis and flavonoids.
- Included various flavonoid subclasses: flavones, flavonols, flavanols, isoflavones, flavanones, anthocyanins.
- Focused on molecular mechanisms of flavonoid action in bone.
Main Results:
- Flavonoids exhibit similar effects on bone loss in postmenopausal and animal models.
- They increase bone mineral density and strength by promoting osteoblastogenesis and osteoclast apoptosis.
- Flavonoids also decrease osteoclastogenesis and enhance neovascularization in fractures.
Conclusions:
- Multiple signaling pathways mediate flavonoid effects on osteoporotic bone.
- Further research is needed to clarify common mechanisms and estrogen receptor interactions.
- More clinical trials are required to assess safety, efficacy, bioavailability, and compare with conventional therapies.
More Related Videos
Related Concept Videos
02:59Cancer Prevention
Some...
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:31Osteoclasts in Bone Remodeling
01:40Bone Remodeling